antiretroviral treatment

TAC wants free treatment for all HIV infected

The Treatment Action Campaign believes antiretroviral treatment should be offered to all HIV-positive citizens, not just those with low CD4 counts.

South Africa's largest HIV lobby group, the Treatment Action Campaign (TAC), is demanding that everyone infected with HIV in the country is offered antiretroviral therapy (ART) immediately after their diagnosis. Currently, less than half (3.1-million) of the country's estimated 6.4-million HIV-infected citizens receive anti-HIV treatment, according to health department data.

Facilitators: HIV Counselling and Testing (HCT)

Health Systems Trust
Closing Date: 
7 December 2014
Health Systems Trust is a dynamic, not-for-profit organisation that supports the development of an equitable and comprehensive health system for the provision of quality health care in South and Southern Africa.
Health Systems Trust wishes to appoint three full-time Facilitators to support the activities of an HIV Counselling and Testing (HCT) project across two provinces in South Africa, i.e. Limpopo and Northern Cape.

Lifelong ARVs for pregnant women, says Health Minister

All pregnant, HIV positive women will go onto lifelong antiretroviral treatment from January, Health Minister Dr Aaron Motsoaledi announced in his health budget vote yesterday.
In addition, people with HIV will start treatment when their CD4 count, which measures immunity, drops to 500 not 350 as at present.
Currently, pregnant HIV-positive women with a CD4 count over 350 only receive ARVs during pregnancy and breastfeeding to prevent mother-to-child HIV transmission.
Next month, the health department will also launch MomConnect, an SMS service for pregnant women, which will send mothers-to-be health messages relevant to their stage of pregnancy.

High incidence of antiretroviral prescribing errors in Nigeria

Antiretroviral prescribing errors are common in Nigeria, according to results of a large prospective study published in PLOS ONE. Errors were detected in the prescriptions of almost all adult patients. Common errors included prescribing incorrect antiretroviral drugs or combinations; prescribing drugs that were contraindicated or that interacted with other medication; and inappropriate frequency or duration of therapy.

TB/HIV programmatic challenges highlighted at ICASA

The presence of tuberculosis (TB) at the initiation of antiretroviral therapy (ART) predicts retention in care, according to a study presented by Dr Enegela at the 17th International Conference on AIDS and STIs in Africa (ICASA), held in Cape Town, South Africa from 7 to 11 December 2013.  

Adults with TB at ART initiation were 2.85 times less likely to be retained in care (p = 0.0014; 95% CI, 1.2-6.4), according to the cross-sectional review of 1262 people who had initiated ART across 12 ARV sites in Nigeria. The review was conducted with people who had been on ART for at least nine months.

HIV and Aids: record numbers in poorer countries receive treatment

HIV infection rates tumble by 33% in a decade, while number of Aids-related deaths falls from 2.3m in 2005 to 1.6m last year

Record numbers of people living in low- and middle-income countries are receiving antiretroviral treatment, and HIV infection rates among children have fallen sharply, the UN has said.

But UNAids, the joint UN programme on HIV and Aids, said there were worrying signs that some countries were not on track to meet global targets and commitments, and more funding was required.

‘Functional cure for HIV’: Dare we hope?

On Sunday, researchers at the 20th annual Conference on Retroviruses and Opportunistic Infections (CROI) in Atlanta, Georgia announced that they had, for the first time, “functionally” cured a baby born with HIV. A "functional cure" refers to state where a person is AIDS-free without the need for HIV drugs, despite a trace of the virus lingering in the body.